Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Market Cap	4.34T
Revenue (ttm)	549.64B
Net Income (ttm)	104.50B
Shares Out	2.40B
EPS (ttm)	43.55
PE Ratio	41.57
Forward PE	36.57
Dividend	16.00 (0.89%)
Ex-Dividend Date	Jul 7, 2025

Volume	2,902,053
Average Volume	1,848,749
Open	1,802.10
Previous Close	1,804.90
Day's Range	1,802.10 - 1,814.90
52-Week Range	1,548.00 - 1,910.00
Beta	0.27
RSI	76.30
Earnings Date	Nov 5, 2025

About NSE:SUNPHARMA

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respira...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1983
• Employees: 43,000
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUNPHARMA

Financial Performance

In 2024, NSE:SUNPHARMA's revenue was 525.78 billion, an increase of 8.42% compared to the previous year's 484.97 billion. Earnings were 109.29 billion, an increase of 14.12%.